Gepirone Vs Placebo in Treatment of Cocaine Dependence - 3

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Pennsylvania
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000189

Purpose

The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Gepirone	Phase II

Drug Information available for: 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Gepirone

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Gepirone Vs Placebo in Treatment of Cocaine Dependence

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment:

Eligibility

Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000189

Locations

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Pennsylvania

Investigators

Principal Investigator:

James Cornish, M.D.

University of Pennsylvania

More Information

Study ID Numbers:	NIDA-00144-3, K20-00144-3
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000189
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Gepirone
Cocaine-Related Disorders
Mental Disorders
Substance-Related Disorders

Disorders of Environmental Origin
Cocaine
Serotonin

Additional relevant MeSH terms:

Serotonin Agonists
Neurotransmitter Agents
Tranquilizing Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Psychotropic Drugs
Central Nervous System Depressants

Pharmacologic Actions
Serotonin Agents
Therapeutic Uses
Anti-Anxiety Agents
Central Nervous System Agents
Antidepressive Agents

ClinicalTrials.gov processed this record on January 15, 2009